Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | COM701 |
Trade Name | |
Synonyms | CGEN-15029|COM-701|COM 701 |
Drug Descriptions |
COM701 is an antibody directed against PVRIG, which interferes with binding to its ligand PVRL2, potentially resulting in increased anti-tumor immune response (J Clin Oncol 35, 2017 (suppl; abstr 3074), PMID: 32345592). |
DrugClasses | |
CAS Registry Number | 2253186-93-3 |
NCIT ID | C156791 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BMS-986207 + COM701 + Nivolumab | BMS-986207 COM701 Nivolumab | 0 | 1 |
COM701 | COM701 | 0 | 1 |
COM701 + Nivolumab | COM701 Nivolumab | 0 | 1 |